
BIOPHEN⢠FVIII:C
Price:
$549.00
Product DescriptionIn US and Canada: For Research Use Only. Not for Use in Diagnostic Procedures.
BIOPHEN FVIII:C is a two-stage chromogenic assay for Factor VIII coagulant activity (FVIII:C) in human citrated plasma or FVIII concentrates, per European Pharmacopoeia and USP methods. Components: R1 (activated FIXa + FX + phospholipids + CaCl?), R2 (Factor Xa chromogenic substrate). Clinical applications: hemophilia A diagnosis and severity classification (severe <1%, moderate 1-5%, mild 5-40%), FVIII concentrate potency testing, monitoring FVIII replacement therapy, and DDAVP response assessment. Note: This assay IS sensitive to emicizumab for emicizumab-treated patients, use BIOPHEN FVIII Variant (227102) instead. Calibrate with BIOPHEN Plasma Calibrator (222101). QC with Normal (223201) and Abnormal (223301) Controls. Use Special Tris-BSA buffer (AR026) for dilutions. CE-IVD. Product Characteristics
Product Components
|
Product Applications
Measurement of Factor VIII:C in research applications.
Associated calibrator and controls are available: BIOPHEN⢠Plasma Calibrator (Ref A222101-RUO), BIOPHEN⢠Normal Control Plasma
(Ref A223201-RUO) and BIOPHEN⢠Abnormal Control Plasma (Ref A223301-RUO).
Certificate of Analysis (COA) |